Predictive value of phosphorylated mammalian target of rapamycin for diseasefree survival in breast cancer patients receiving neoadjuvant chemotherapy

Publisher： Spandidos Publications

E-ISSN： 1792-1082|8|6|2642-2648

ISSN： 1792-1074

Source： Oncology Letters, Vol.8, Iss.6, 2014-01, pp. : 2642-2648

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy

By Fuksa L.   Micuda S.   Grim J.   Ryska A.   Hornychova H.  

Cancer Investigation, Vol. 30, Iss. 9, 2012-10 ,pp. : 663-678

Informa Healthcare

Access to resources Recommend Favorite

Immunohistochemical analysis of phosphorylated mammalian target of rapamycin and its downstream signaling components in invasive breast cancer

By              

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 5246-5254

Spandidos Publications

Access to resources Recommend Favorite

Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy

By Aas T.   Geisler S.   Eide G.E.   Haugen D.F.   Varhaug J.E.   Bassoe A.M.   Thorsen T.   Berntsen H.   Borresen-Dale A.-L.   Akslen L.A.   Lonning P.E.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 438-446

Elsevier

Access to resources Recommend Favorite

Plasma and tissue proteomic prognostic factors of response in primary breast cancer patients receiving neoadjuvant chemotherapy

By                

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 355-361

Spandidos Publications

Access to resources Recommend Favorite

Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis

By                        

Oncology Letters, Vol. 8, Iss. 1, 2014-01 ,pp. : 397-403

Spandidos Publications

Access to resources Recommend Favorite